Dear Colleagues and Friends,
It is with great pleasure that we invite you to partake in the 1st CannX Brazil – The International Congress of Cannabinoid Medicine, to be held on November 12th to 14th 2018, at the Centro de Convenções Rebouças, in São Paulo/Brazil.
From 1975 to 1982, a partnership between the Israeli research group lead by Raphael Mechoulam and the Brazilian team lead by Elisaldo Carlini yielded five articles revealing to the world the powerful anti-epileptic properties of cannabidiol. Nowadays, thousands of epileptic people around the world are enjoying the benefits of those pioneering studies and many more are having their suffering significantly mitigated by the growing number of medicinal applications for Cannabis and cannabinoids.
Brazil is a Latin America´s regional power with more than two hundred million citizens. During the second semester of 2018, the Brazilian government is expected to publish the rules that will regulate local production, distribution, research and medicinal use of cannabis and its derivatives. This step has been urgently expected by thousands of patients for whom cannabinoids represent hope for a new, longer and much better life.
In this context, about four decades later, Israelis and Brazilians are joining efforts again to help improve in Brazil and Latin America the knowledge about this ancient, yet revolutionary medicine. The first step in this partnership will be the realization of the 1st CannX Brazill: The International Congress of Cannabinoid Medicine.
This meeting will bring together some of the most important leaders in in the research of cannabinoid medicine from Israel and from around the world. It will include the participations of leading experts from Brazil and Latin America, as well as local authorities. This will contribute both regionally and globally to improve even more the growing scientific connection in the field.
The congress focus will be both on research and clinical experiences – with special emphasis on the latter one. Some of the topics covered will include the homeostatic role of the endocannabinoid system and the use of Cannabis and cannabinoids in clinical practice for the treatment of pain, cancer, autism, epilepsy and for the integrative care of the elderly.
Therefore, we invite you to take part in this effort and help the community to raise awareness to the potential benefits of cannabis and/or cannabinoids to the life of patients with epilepsy, cancer and other diseases that affect so many throughout the world.
With my best regards,
Congress Chairman - 1st CannX Brazil - International Congress for Cannabinoid Medicines
Socio diretor de estratégia e crescimento da Indeov, empresa que oferece acesso e monitoramento terapêutico para a cannabis medicinal.
Atua há 21 anos pela Symnetics como agente de inovação e transformação em parceria com diversas organizações.
Professor dos programas executivos da Fia, Bs...
Graduated in Biological Sciences from the Mackenzie University (1999) Master (2002) and PhD in Sciences (2006) by the Faculty of Veterinary Medicine and Zootechnics of the University of São Paulo. Post-doctoral degree from the Laboratory of Pharmacology of the Institut National de la Sante et la Rec...View more
Social businesswoman, has worked with medical cannabis since 2014. With experience in the US and Brazil, she has been dedicating the last years in the mission to bring therapeutic relief to chronic patients, connecting patients, doctors and international producers. With the commitment to positively ...View more
Graduated from the State University of Campinas. He completed his Masters and PhD in Physiology and Biophysics from the State University of Campinas - Unicamp in 1992 and 1998, respectively. He obtained a PhD in INSERM-France, where he worked with electrophysiology of the trigeminal system. She did ...View more
Graduated in Biological Sciences from the Federal University of Rio de Janeiro, a Master‘s Degree in Biological Sciences from the Federal University of Rio de Janeiro, and a PhD in Biological Sciences (Biophysics) from the Federal University of Rio de Janeiro. Department at the Massachusetts Institu...View more
Cynthia Petrone-Hudock comes to New Frontier Data a 12+ year veteran of healthcare information technology, assisting healthcare systems in leveraging enabling technology to transform care. With a mission to improve the quality of care while reducing the cost of healthcare, her portfolio includes el...View more
Mathematical. Professor, Researcher and Executive Consultant in innovation, teaching and learning technologies, cognitive computing, disruptive and didactic methodologies.
Divide your time into two worlds: academic and business. Researcher at GAESI / USP (University of São Paulo), Brazil. CEO o...
He holds a medical degree from the Federal University of São Paulo (1957) and a master‘s degree in Psychopharmacology - Yale University (1962). Currently, he is from the Federal University of São Paulo, member of the Expert Advisory Panel on Drug Dependence and Alcohol Problems (7th Term) - World He...View more
1) Academic background: 2014-present - Full Professor Pharmacology Department, Biomedical Science Institute, University of São Paulo 2009-2014 - Full Professor Cell Biology Department, Biomedical Science Institute, University of São Paulo 2004-2009 - Associate Professor Cell Biology Department, Biom...View more
Pharmacist, PhD in Psychopharmacology (2010), Visiting Researcher at the Max Planck Institute of Psychiatry (2007-2008). Experience of 15 years as a researcher in the field of cannabinoids. Speaker at several international events. Awarded by the Brazilian societies of Pharmacology (SBFTE) and Neuros...View more
Education: Medical-UFRGS, 1976-1981 Residency in Internal Medicine, HC-UFRGS, 1982-1983 PhD in Pharmacology, FMRP-USP, 1984-1987. Advisor: Dr. Antonio Waldo Zuardi Postdoctoral fellow, Department of Neuroscience and Psychiatry, University of Manchester. Supervisor: Dr. J.F.W. Deakin Livre-docencia, ...View more
Graduated in biomedicine and medicine, master and doctor in clinical medicine - clinical pharmacology. He has been working for 20 years in R & D, clinical research, translational medicine and drug safety. Experience in medical department management of pharmaceutical industries, strategic consulting ...View more
Associate Professor at the Biomedical Sciences Institute of UFRJ. Doctor (1987) by UFRJ, Master (1991) and Doctorate (1996), by the Institute of Biophysics UFRJ. Post-Doctorate (2005) at MGH / Harvard Medical School. 28 years dedicated to the study of neurogenesis in the neonatal and adult brain. Sp...View more
Master in Sociology. Coordinator of the Center for Studies on Security and Citizenship at Candido Mendes University. Former general director of the penitentiary system and former police ombudsman of the state of Rio de Janeiro. Member of the board of the International Drug Policy Consortium.
Dr. Karyemaitre Aliffe is a multilingual, multicultural physician-scientist who brings life to science and vitality to our concepts of medicine. Having taught at Harvard and Stanford, he has been welcomed to over 50 countries as a guest speaker, giving insightful presentations to community groups an...View more
Preceptor of the medical residency of the Children‘s Hospital of the John Paul II Children‘s Hospital - FHEMIG - Belo Horizonte - Former president of Abrepe - Author of three books - Child Neurology - Child Day Neurology at the Mother Day Hospital - Belo Horizonte
Margarete Brito, lawyer with specialization in social responsibility and third sector by the Federal University of Rio de Janeiro. In 2013 she became aware of the medicinal use of cannabis, through the needs of her daughter and became a major activist in the field of medical cannabis in Brazil, toda...View more
Dr. Maria Fernanda Arboleda is a graduate of ‘Pontificia Universidad Javeriana’, located in Bogota, Colombia, where she received her medical degree. Later, she obtained her specialty certificate in Anesthesia and following, a Pain Management and Palliative Care Fellowship diploma from the ‘Universid...View more
• A pediatric neurologiest working since 2009 as a clinical director of the Early Childhood Services in the Autism Center in Assaf Harofeh Medical Center, Israel. The Autism Center is a national center that is involved in diagnosis, treatment and research in autism spectrum disorders; a combined pro...View more
Raquel Peyraube is a Uruguayan Medical Doctor graduated at the Medicine School of the Universidad de la República and specialist on Endocannabinology and Drug field. She is the founder and current president of the Uruguayan Society of Endocannabinology (SUEN). Throughout her career she was involved ...View more
Paulistano, born in 1984, is a researcher and doctor of neuroscience at the Federal University of São Paulo. He investigates the cannabinoid system and its relationship with neurobiological and behavioral mechanisms in the problematic use of substances, especially alcohol and cocaine. Together with ...View more
Ricardo A. De Melo Reis
Associate Professor and CNPq Researcher PQ2, Lab Neurochemistry, Biophysics Institute, Federal University Rio de Janeiro
• BA in Biology University of Brasilia (UnB) 1984-1988,
• Master Biophysics Federal University Rio de Janeiro (UFRJ) 1989-1991 n
Chemical Engineer, Master in Cellular and Molecular Biology, MBA in Intellectual Property, MBA in Business Management. Professor in Post-Graduation in Innovation Management at Unicamp and Instituto Butantan.
Graduated and specialized in Children's Neurology by USP-SP. Master in Human Communication Disorders at UNIFESP-SP and Doctor of Health Sciences at ABC Medical School where he currently works as coordinator of postgraduate courses. Director of the Brazilian Society of Child Neurology - SBNI, since 2...View more
Tarso Araujo Silva graduated in Journalism from the School of Communication of the Federal University of Rio de Janeiro (ECO-Ufrj / RJ), since 2002. He started in Journalism as a general reporter for Globo.com (RJ), where he remained until 2003. During this period also wrote for the publications of ...View more
Specialist in sanitary surveillance - Specialist in regulation and sanitary surveillance in the Controlled Products Management of ANVISA since 2005. - Coordinator of the Coordination of Trade and Special Control of Controlled Products since 2016.
Adjunct Professor, Faculty of Pharmacy, UFRJ. Master and PhD in Toxicology and Toxicological Analysis by FCF-USP in partnership with IML-SP. Post-doctorate in Experimental Toxicology by FMVZ-USP. Specialist in Teaching in Health by UFRGS. Experience in toxicological analysis and toxicity assessment....View more
Event VenueRebouças Convention Center
Operating for more than 34 years, Centro de Convençoes Rebouças (Rebouças Convention Center) specializes in leasing spaces for events. It has 17 environments with air-conditioning that can accommodate up to 2,300 participants.
You can easily reach Centro de Convençoes Rebouças through the following avenues: Avenida Paulista, Avenida Rebouças and Avenida Doutor Arnaldo – next to Clinicas Metro Station.
Av. Rebouças, 600 | 05402-000 | São Paulo | SP